Acthera Therapeutics AG

Acthera is a Swiss biotech start-up that develops an entirely novel targeted therapy technology based on Hard-Shelled Liposomes (HSLs). The proprietary technology has the potential to address the most critical challenge in drug development – creating more efficacious, safer drugs. Acthera is growing to become a fully integrated drug discovery and development biotechnology company. It is located in Basel, one of the best European research & development hubs.